Found: 19
Select item for more details and to access through your institution.
RACK1 antagonizes TNF-α-induced cell death by promoting p38 activation.
- Published in:
- Scientific Reports, 2015, p. 14298, doi. 10.1038/srep14298
- By:
- Publication type:
- Article
A Novel Humanized Anti-Abrin A Chain Antibody Inhibits Abrin Toxicity In Vitro and In Vivo.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.831536
- By:
- Publication type:
- Article
Serum HE4 is more suitable as a biomarker than CA125 in Chinese women with benign gynecologic disorders.
- Published in:
- African Health Sciences, 2014, v. 14, n. 4, p. 913, doi. 10.4314/ahs.v14i4.20
- By:
- Publication type:
- Article
Unveiling novel insights into human IL-6 − IL-6R interaction sites through 3D computer-guided docking and systematic site mutagenesis.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-69429-w
- By:
- Publication type:
- Article
Development and characterization of an antibody that recognizes influenza virus N1 neuraminidases.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0302865
- By:
- Publication type:
- Article
Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation.
- Published in:
- BMC Immunology, 2012, v. 13, n. 1, p. 40, doi. 10.1186/1471-2172-13-40
- By:
- Publication type:
- Article
Engineered AXL<sup>−ECD</sup>-Fc variants that abolish the AXL/Gas6 interaction suppress tumor cell migration.
- Published in:
- Oncology Letters, 2019, v. 17, n. 6, p. 5784
- By:
- Publication type:
- Article
Structure-based virtual screening and characterization of a novel IL-6 antagonistic compound from synthetic compound database.
- Published in:
- Drug Design, Development & Therapy, 2016, v. 10, p. 4091, doi. 10.2147/DDDT.S118457
- By:
- Publication type:
- Article
The inhibition of CD4<sup>+</sup> T cell proinflammatory response by lactic acid is independent of monocarboxylate transporter 1.
- Published in:
- Scandinavian Journal of Immunology, 2021, v. 94, n. 6, p. 1, doi. 10.1111/sji.13103
- By:
- Publication type:
- Article
A novel human anti‐AXL monoclonal antibody attenuates tumour cell migration.
- Published in:
- Scandinavian Journal of Immunology, 2019, v. 90, n. 2, p. N.PAG, doi. 10.1111/sji.12777
- By:
- Publication type:
- Article
Novel CRISPR/Cas9-mediated knockout of LIG4 increases efficiency of site-specific integration in Chinese hamster ovary cell line.
- Published in:
- Biotechnology Letters, 2022, v. 44, n. 9, p. 1063, doi. 10.1007/s10529-022-03282-7
- By:
- Publication type:
- Article
Multi-parametric analysis reveals enhanced G2-phase arrest of an optimized anti-HER2 antibody to inhibit breast cancer.
- Published in:
- Biotechnology Letters, 2017, v. 39, n. 9, p. 1309, doi. 10.1007/s10529-017-2364-8
- By:
- Publication type:
- Article
The Peptide Derived from erbB2 Auto-Inhibitor Herstatin Shared in the Same Epitope and Function with Functional Antibody 2C4.
- Published in:
- Molecular Biotechnology, 2012, v. 51, n. 2, p. 174, doi. 10.1007/s12033-011-9454-y
- By:
- Publication type:
- Article
Rapid detection of whole active ricin using a surface‐enhanced Raman scattering‐based sandwich immunoassay.
- Published in:
- Journal of Raman Spectroscopy, 2023, v. 54, n. 2, p. 137, doi. 10.1002/jrs.6464
- By:
- Publication type:
- Article
Arg9 facilitates the translocation and downstream signal inhibition of an anti-HER2 single chain antibody.
- Published in:
- BMC Research Notes, 2012, v. 5, n. 1, p. 336, doi. 10.1186/1756-0500-5-336
- By:
- Publication type:
- Article
A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus.
- Published in:
- eLife, 2024, p. 1, doi. 10.7554/eLife.91181
- By:
- Publication type:
- Article
Functional epitopes and neutralizing antibodies of vaccinia virus.
- Published in:
- Frontiers in Microbiology, 2023, p. 1, doi. 10.3389/fmicb.2023.1255935
- By:
- Publication type:
- Article
Novel anti-CD38 humanized mAb SG003 possessed enhanced cytotoxicity in lymphoma than Daratumumab via antibody-dependent cell-mediated cytotoxicity.
- Published in:
- BMC Biotechnology, 2019, v. 19, n. 1, p. 1, doi. 10.1186/s12896-019-0524-8
- By:
- Publication type:
- Article
pH Low Insertion Peptide-Modified Programmed Cell Death-Ligand 1 Potently Suppresses T-Cell Activation Under Acidic Condition.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.794226
- By:
- Publication type:
- Article